Revision 1

#50752Store at -20C

Cell Signaling Technology

Orders: 877-616-CELL (2355) [email protected]

Support: 877-678-TECH (8324)

Web: [email protected] cellsignal.com

3 Trask LaneDanversMassachusetts01923USA
For Research Use Only. Not for Use in Diagnostic Procedures.
Applications:

WB, IP

REACTIVITY:

H

SENSITIVITY:

Endogenous

MW (kDa):

65

SOURCE:

Rabbit

UniProt ID:

#Q9UH73

Entrez-Gene Id:

1879

Product Information

Product Usage Information

Application Dilution
Western Blotting 1:1000
Immunoprecipitation 1:100

Storage

Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Store at –20°C. Do not aliquot the antibody.

Specificity / Sensitivity

EBF1 Antibody recognizes endogenous levels of total EBF1 protein. This antibody may detect nonspecific bands of unknown origin at 41 and 110 kDa. This antibody may cross-react with EBF2 and EBF3.

Species Reactivity:

Human

Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Gly500 of human EBF1 protein. Antibodies are purified by peptide affinity chromatography.

Background

Early B-cell factor 1 (EBF1), also referred to as COE1, is a pioneering transcription factor that is crucial for defining B-cell lineage. In hematopoiesis, EBF1 promotes the expression of genes that specify B-cell lineage commitment, such as iFoxO1/i, iPAX5/i, and iIRF-4/i, while also repressing the expression of transcription factor genes that promote alternate lineages (1,2). EBF1 has also been reported to play a role in olfactory neuronal cell, adipocyte, and early osteoclast differentiation (3-6). Due to the crucial role of EBF1 in B-cell development, mutations in EBF1 can lead to the development of B-cell acute lymphoblastic leukemia (B-ALL) (7,8). EBF1 expression is also suppressed in some solid tumor cancers, including genomic loss in breast cancer and down-regulation in pancreatic ductal adenocarcinomas (9,10). Lower expression levels of EBF1 also correlate with lower survival rates in patients with cholangiocarcinoma and colorectal carcinoma (CRC), and induced overexpression of EBF1 in CRC cell lines induces cell cycle arrest and apoptosis in vivo and in vitro (11,12).

  1. Miyai, T. et al. (2018) Genes Dev 32, 112-126.
  2. Li, R. et al. (2018) Genes Dev 32, 96-111.
  3. Tsai, R.Y. and Reed, R.R. (1997) J Neurosci 17, 4159-69.
  4. Wang, S.S. et al. (2004) Development 131, 1377-88.
  5. Akerblad, P. et al. (2005) Physiol Genomics 23, 206-16.
  6. Nieminen-Pihala, V. et al. (2021) Bone 146, 115884.
  7. Kuiper, R.P. et al. (2007) Leukemia 21, 1258-66.
  8. Mullighan, C.G. et al. (2007) Nature 446, 758-64.
  9. Neve, R.M. et al. (2006) Cancer Cell 10, 515-27.
  10. Jones, S. et al. (2008) Science 321, 1801-6.
  11. Armartmuntree, N. et al. (2018) Redox Biol 14, 637-644.
  12. Shen, Z. et al. (2020) Front Oncol 10, 1035.

Species Reactivity

Species reactivity is determined by testing in at least one approved application (e.g., western blot).

Western Blot Buffer

IMPORTANT: For western blots, incubate membrane with diluted primary antibody in 5% w/v nonfat dry milk, 1X TBS, 0.1% Tween® 20 at 4°C with gentle shaking, overnight.

Applications Key

WB: Western Blotting IP: Immunoprecipitation

Cross-Reactivity Key

H: human M: mouse R: rat Hm: hamster Mk: monkey Vir: virus Mi: mink C: chicken Dm: D. melanogaster X: Xenopus Z: zebrafish B: bovine Dg: dog Pg: pig Sc: S. cerevisiae Ce: C. elegans Hr: horse GP: Guinea Pig Rab: rabbit All: all species expected

Trademarks and Patents

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit cellsignal.com/trademarks for more information.

限制使用

除非 CST 的合法授书代表以书面形式书行明确同意,否书以下条款适用于 CST、其关书方或分书商提供的书品。 任何书充本条款或与本条款不同的客书条款和条件,除非书 CST 的合法授书代表以书面形式书独接受, 否书均被拒书,并且无效。

专品专有“专供研究使用”的专专或专似的专专声明, 且未专得美国食品和专品管理局或其他外国或国内专管机专专专任何用途的批准、准专或专可。客专不得将任何专品用于任何专断或治专目的, 或以任何不符合专专声明的方式使用专品。CST 专售或专可的专品提供专作专最专用专的客专,且专用于研专用途。将专品用于专断、专防或治专目的, 或专专售(专独或作专专成)或其他商专目的而专专专品,均需要 CST 的专独专可。客专:(a) 不得专独或与其他材料专合向任何第三方出售、专可、 出借、捐专或以其他方式专专或提供任何专品,或使用专品制造任何商专专品,(b) 不得复制、修改、逆向工程、反专专、 反专专专品或以其他方式专专专专专品的基专专专或技专,或使用专品开专任何与 CST 的专品或服专专争的专品或服专, (c) 不得更改或专除专品上的任何商专、商品名称、徽专、专利或版专声明或专专,(d) 只能根据 CST 的专品专售条款和任何适用文档使用专品, (e) 专遵守客专与专品一起使用的任何第三方专品或服专的任何专可、服专条款或专似专专

Revision 1
#50752

EBF1 Antibody

Western Blotting Image 1: EBF1 Antibody Expand Image
使用 EBF1 Antibody(上图)和 β-Actin (D6A8) Rabbit mAb #8457(下图)对不同细胞系的提取物进行蛋白质印迹分析。HeLa 细胞中 EBF1 蛋白的低表达与非淋巴细胞系中的预测表达模式一致。
Immunoprecipitation Image 1: EBF1 Antibody Expand Image
对 REH 细胞提取物 EBF1 蛋白进行免疫沉淀分析。泳道 1 为 10% input,泳道 2 为 Normal Rabbit IgG #2729,泳道 3 为 EBF1 Antibody。使用 EBF1 Antibody 进行蛋白质印迹分析。Anti-rabbit IgG, HRP-linked Antibody #7074 用作二抗。